✦ LIBER ✦

Cost-effectiveness analyses in gynecologic oncology: methodological quality and trends

✍ Scribed by Michael R Manuel; Lee-may Chen; Aaron B Caughey; Leslee L Subak

Book ID: 113959194
Publisher: Elsevier Science
Year: 2004
Tongue: English
Weight: 283 KB
Volume: 93
Category: Article
ISSN: 0090-8258
DOI: 10.1016/j.ygyno.2004.01.030

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Utility and cost-effectiveness of preope

Utility and cost-effectiveness of preoperative autologous blood donation in gynecologic and gynecologic oncology patients

✍ Neil S Horowitz; Randall K Gibb; Nicole E Menegakis; David G Mutch; Janet S Rade 📂 Article 📅 2002 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 87 KB

Cost-effectiveness of deep venous thromb

Cost-effectiveness of deep venous thrombosis prophylaxis in gynecologic oncology surgery

✍ G.Larry Maxwell; Evan R Myers; Daniel L Clarke-Pearson 📂 Article 📅 2000 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 207 KB

PCN127 METHODS FOR INDIRECT COMPARISON O

PCN127 METHODS FOR INDIRECT COMPARISON OF EFFECTIVENESS IN COST-EFFECTIVENESS ANALYSES OF ONCOLOGY AGENTS: THE PROPORTIONAL HAZARDS ASSUMPTION MATTERS

✍ P. Ducournau; Z. Zhao; B. Barber; S. Gao; C.N. Graham 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 57 KB

Conducting cost-effectiveness analyses o

Conducting cost-effectiveness analyses of type 2 diabetes in low- and middle-income countries: can locally generated observational study data overcome methodological limitations?

✍ SeiHyun Baik; Antônio Roberto Chacra; Li Yuxiu; Jeremy White; Serdar Güler; Zafa 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 324 KB

PCN68 US AND CANADIAN COST-EFFECTIVENESS

PCN68 US AND CANADIAN COST-EFFECTIVENESS ANALYSES OF US ONCOLOGY TRIAL 9735 PROVIDE ADDITIONAL RATIONALE FOR AVOIDING ANTHRACYCLINES IN THE ADJUVANT TREATMENT OF OPERABLE BREAST CANCER

✍ C Chin; S Jones; S Verma; L Bernard; MF Thompson; N Mittmann; BCF Chan; M Tangir 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 71 KB

How Do Cost-Effectiveness Analyses Infor

How Do Cost-Effectiveness Analyses Inform Reimbursement Decisions for Oncology Medicines in Canada? The Example of Sunitinib for First-Line Treatment of Metastatic Renal Cell Carcinoma

✍ Isabelle Chabot; Angela Rocchi 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 177 KB